BioVie Inc.
BIVI
$0.8502
$0.01021.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 21.99% | -22.56% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 76.92% | -13.95% | |||
| Operating Income | -76.92% | 13.95% | |||
| Income Before Tax | -71.30% | 15.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -71.30% | 15.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -71.30% | 15.97% | |||
| EBIT | -76.92% | 13.95% | |||
| EBITDA | -78.01% | 14.12% | |||
| EPS Basic | 34.91% | 13.42% | |||
| Normalized Basic EPS | 30.28% | 19.70% | |||
| EPS Diluted | 34.29% | 15.70% | |||
| Normalized Diluted EPS | 30.28% | 19.70% | |||
| Average Basic Shares Outstanding | 145.64% | 4.67% | |||
| Average Diluted Shares Outstanding | 145.64% | 4.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||